Skip to content

Clinical trials

Phase 1/2 Carcinoma, Squamous Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 1/2 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20103
20131
20174
20181
20195
20203
20232
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting7
Active, not recruiting2
Terminated2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Advaxis, Inc.1
AstraZeneca1
BPGbio1
Bruce Robinson, MD1
Cascadian Therapeutics Inc.1
Dana-Farber Cancer Institute1
Hookipa Biotech GmbH1
ImmVira Pharma Co. Ltd1
ImmunityBio, Inc.1
InduPro, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell28
Squamous Cell Carcinoma of Head and Neck12
Carcinoma, Non-Small-Cell Lung9
Head and Neck Neoplasms9
Carcinoma6
Melanoma6
Neoplasms6
Colorectal Neoplasms5
Carcinoma, Renal Cell4
Lung Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.